Patrys Limited: Melbourne Biotech’s Antibody‑Based Cancer Therapy Breakthroughs
Patrys Limited: Melbourne biotech firm pioneers antibody‑based cancer therapies amid stock volatility, offering a glimpse of future oncology breakthroughs.
2 minutes to read